{"name":"Ian F. Pollack, M.D.","slug":"ian-f-pollack-m-d","ticker":"","exchange":"","domain":"","description":"Ian F. Pollack, M.D. is a biotechnology company focused on developing innovative peptide vaccines for cancer treatment. The company's pipeline includes two early-stage candidates, both in Phase 1 trials, aimed at enhancing the immune response against tumors.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA3cGxEN0MyQmNlcVVYd1JZbUJHMm4xMDh2UUhDWEdRODE4cUZmYUp1XzJhckxqNEY0bTQzMGVBS0xfdGdrS082WDR1NEpuSzRsV2V1Ynp4R1J1MzZ1ZlBN?oc=5","date":"2018-05-01","type":"pipeline","source":"NEJM","summary":"Expression of p53 and Prognosis in Children with Malignant Gliomas - NEJM","headline":"Expression of p53 and Prognosis in Children with Malignant Gliomas","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}